Business & Financial News, Breaking US & International News | Reuters
Edition:
United States

Biotechnology & Medical Research

Page 1

ZHONGYUAN UNION CELL & GENE ENGINEERING to establish new subsidiary

Monday, 11 Apr 2016 08:00pm EDT

ZHONGYUAN UNION CELL & GENE ENGINEERING CORP., LTD:Says establishment of a wholly owned subsidiary in Tianjin, with a registered capital of 5 mln yuan.The new subsidiary will be engaged in technology development of biotechnology field.

ZHONGYUAN UNION CELL & GENE ENGINEERING subsidiary to establish new subsidiary

Monday, 11 Apr 2016 08:00pm EDT

ZHONGYUAN UNION CELL & GENE ENGINEERING CORP., LTD:United States-based wholly owned subsidiary, Vcan Bio USA Co., Ltd. to establish a new subsidiary in U.S., namely HebeCell Corp.HebeCell Corp. with a registered capital of $5,007,200.The new subsidiary will be engaged in declaration work in U.S. of research and development product.

ZHONGYUAN UNION CELL & GENE ENGINEERING to establish new subsidiary in United States

Monday, 11 Apr 2016 08:00pm EDT

ZHONGYUAN UNION CELL & GENE ENGINEERING CORP., LTD:To establish a wholly owned subsidiary in the United States, namely VcanBio Center for Translational Biotechnology Corp.The new subsidiary with a registered capital of $5 mln.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider : Thomson Reuters StreetEvents
$75.00
Provider : Thomson Reuters StreetEvents
$75.00
Provider : Edison Investment Research
$10.00
Provider : Thomson Reuters StreetEvents
$75.00
Provider : Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.